Log in to save to my catalogue

International collaborative actions and transparency to understand, diagnose, and develop therapies...

International collaborative actions and transparency to understand, diagnose, and develop therapies...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_18d94c76875644f1a362449cf8bf26d7

International collaborative actions and transparency to understand, diagnose, and develop therapies for rare diseases

About this item

Full title

International collaborative actions and transparency to understand, diagnose, and develop therapies for rare diseases

Publisher

London: Nature Publishing Group UK

Journal title

EMBO molecular medicine, 2019-05, Vol.11 (5), p.1-n/a

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Rare diseases, which affect over 350 million people worldwide and frequently go undiagnosed or misdiagnosed for years, suffer from sparse and dispersed medical knowledge leading to even rarer approved and effective therapeutic options for patients. A vast, unmet need for research and investment to advance diagnostic capabilities and therapeutic dev...

Alternative Titles

Full title

International collaborative actions and transparency to understand, diagnose, and develop therapies for rare diseases

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_18d94c76875644f1a362449cf8bf26d7

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_18d94c76875644f1a362449cf8bf26d7

Other Identifiers

ISSN

1757-4676

E-ISSN

1757-4684

DOI

10.15252/emmm.201910486

How to access this item